Dr. David Y. Josephson, MD

Dr. Josephson practices at Tower Outpatient Surgery Center in Los Angeles, California.

Dr. Josephson's NPI, 1063510840, was assigned on September 20, 2006. Dr. Josephson graduated from Albert Einstein College of Medicine in 1999. Dr. Josephson holds California license A75701.

Dr. Josephson's primary practice is Tower Outpatient Surgery Center, at 8635 W 3rd St, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 659-9408.

Dr. Josephson's primary practice is Tower Outpatient Surgery Center in Los Angeles, California. Dr. Josephson is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Tower Urology. Dmand AI also links Dr. Josephson to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Josephson practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Josephson's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Josephson is board certified in urology by the American Board of Urology. Dr. Josephson is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Josephson treats.

CMS data shows 85,818 Medicare services from Dr. Josephson across 83 procedure codes in 2024, for 1,511 Medicare patients. Medicare paid $1,113,769 for them.

CMS counts 1,511 Medicare patients who saw Dr. Josephson in 2024. The largest group is 75 to 84, with 697 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Josephson's median patient age at 73, with 13% women.

In 2024, Dr. Josephson wrote 3,981 Medicare Part D claims for 796 patients. 78% of them were for generic drugs. CMS names the drug for 3,808 of them, across 41 drugs with 11 or more claims each, at $1,400,771 in total drug cost. In 2023, CMS named 4,149 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Josephson for performance year 2024, reported individually. Dr. Josephson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Josephson as offering telehealth. CMS counts 58 procedures of prostate resection by Dr. Josephson, more than 98% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Josephson, published from 2011 to 2023. 2011 was the busiest year, with 3. Dr. Josephson's most frequent co-authors are Clayton S. Lau, MD, Timothy Wilson, MD and Brian Francis Chapin, MD.

Dmand AI links Dr. Josephson to 5 clinical trials, 2 of them phase 1/2 studies. 1 is still active or recruiting. Conditions studied include Non-Muscle Invasive Bladder Neoplasms, Prostatic Neoplasms and Prostatic Neoplasms, Castration-Resistant.

CMS Open Payments shows 496 general payments to Dr. Josephson from 60 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Abbvie Inc. paid the most, $47,177.

Dmand AI lists 5 awards for Dr. Josephson, most recently America's Top Doctors in 2014.

Dr. Josephson graduated from Albert Einstein College of Medicine in 1999. Dr. Josephson is a member of ACS.

Dr. Josephson is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.